Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection

References

• Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301.
   PubMed Web of Science ®Google Scholar
• Arias CA, Murray BE. The rise of the enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266–278.
   PubMed Web of Science ®Google Scholar
• Rosselli Del Turco E, Bartoletti M, Dahl A, et al. How do I manage a patient with enterococcal bacteraemia? Clin Microbiol Infect. 2021;27(3):364–271.
   PubMed Web of Science ®Google Scholar
• López-Luis BA, Sifuentes-Osornio J, Lambraño-Castillo D, et al. Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: a 10-year study in a tertiary-care Centre in Mexico City. J Glob Antimicrob Resist. 2021;24:198–204.
   PubMed Web of Science ®Google Scholar
• Lee T, Pang S, Abraham S, et al. Antimicrobial-resistant CC17 Enterococcus faecium: the past, the present and the future. J Glob Antimicrob Resist. 2019;16:36–47.
   PubMed Web of Science ®Google Scholar
• Gorrie C, Higgs C, Carter G, et al. Genomics of vancomycin-resistant Enterococcus faecium. Microb Genom. 2019;5:e000283.
   Web of Science ®Google Scholar
• Ben RJ, Lu JJ, Young TG, et al. Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan. J Formos Med Assoc. 1996;95(12):946–949.
   PubMed Web of Science ®Google Scholar
• Kuo AJ, Shu JC, Liu TP, et al. Vancomycin-resistant Enterococcus faecium at a university hospital in Taiwan, 2002-2015: fluctuation of genetic populations and emergence of a new structure type of the Tn1546-like element. J Microbiol Immunol Infect. 2018;51(6):821–828.
   PubMedGoogle Scholar
• Butler AM, Olsen MA, Merz LR, et al. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infect Control Hosp Epidemiol. 2010;31(1):28–35.
   PubMed Web of Science ®Google Scholar
• Jiang HL, Zhou Z, Wang LS, et al. The risk factors, costs, and survival analysis of invasive VRE infections at a medical center in Eastern Taiwan. Int J Infect Dis. 2017;54:18–24.
   PubMed Web of Science ®Google Scholar
• McNeil SA, Malani PN, Chenoweth CE, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis. 2006;42(2):195–203.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Jun YH, Choi HJ, et al. Impact of enterococcal bacteremia in liver transplant recipients. Transplant Proc. 2019;51(8):2766–2770.
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Pliakos EE, Zervou FN, et al. MRSA and VRE colonization in solid organ transplantation: a meta-analysis of published studies. Am J Transplant. 2014;14(8):1887–1894.
   PubMed Web of Science ®Google Scholar
• Gearhart M, Martin J, Rudich S, et al. Consequences of vancomycin-resistant enterococcus in liver transplant recipients: a matched control study. Clin Transplant. 2005;050824032258001–050824032258006.
   Web of Science ®Google Scholar
• Wang JL, Hsueh PR. Therapeutic options for infections due to vancomycin-resistant enterococci. Expert Opin Pharmacother. 2009;10(5):785–796.
   PubMed Web of Science ®Google Scholar
• Kishor K, Dhasmana N, Kamble SS, et al. Linezolid induced adverse drug reactions - an update. Curr Drug Metab. 2015;16(7):553–559.
   PubMed Web of Science ®Google Scholar
• Britt NS, Potter EM, Patel N, et al. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients. Clin Infect Dis. 2015;61(6):871–878.
   PubMed Web of Science ®Google Scholar
• Britt NS, Potter EM, Patel N, et al. Comparative effectiveness and safety of standard-, medium-, and high-dose daptomycin strategies for the treatment of vancomycin-resistant enterococcal bacteremia among veterans affairs patients. Clin Infect Dis. 2017;64(5):605–613.
   PubMed Web of Science ®Google Scholar
• Chen CL, Kabiling CS, Concejero AM. Why does living donor liver transplantation flourish in asia? Nat Rev Gastroenterol Hepatol. 2013;10(12):746–751.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 20th informational supplement, M100–S20. Wayne (PA): CLSI; 2010.
   Google Scholar
• Prematunge C, MacDougall C, Johnstone J, et al. VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and Meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):26–35.
   PubMed Web of Science ®Google Scholar
• Bossaer JB, Hall PD, Garrett-Mayer E. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE . Support Care Cancer. 2010;19(2):231–237.
   PubMed Web of Science ®Google Scholar
• Peel T, Cheng AC, Spelman T, et al. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect. 2012;18(4):388–394.
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Zimmer SM, Klein M, et al. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327–333.
   PubMed Web of Science ®Google Scholar
• Orloff SL, Busch AM, Olyaei AJ, et al. Vancomycin-resistant enterococcus in liver transplant patients. Am J Surg. 1999;177(5):418–422.
   PubMed Web of Science ®Google Scholar
• Russell DL, Flood A, Zaroda TE, et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant. 2008;8(8):1737–1743.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim SI, Choi JY, et al. Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients. Korean J Intern Med. 2015;30(5):694–704.
   PubMed Web of Science ®Google Scholar
• Arias CA, Contreras GA, Murray BE. Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect. 2010;16(6):555–562.
   PubMed Web of Science ®Google Scholar
• Ikuta S, Tanimura K, Yasui C, et al. Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery. J Infect Chemother. 2011;17(3):388–391.
   PubMed Web of Science ®Google Scholar
• Whang DW, Miller LG, Partain NM, et al. Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections. Antimicrob Agents Chemother. 2013;57(10):5013–5018.
   PubMed Web of Science ®Google Scholar
• Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355(7):653–665.
   PubMed Web of Science ®Google Scholar
• Chuang YC, Lin HY, Chen PY, et al. Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible Enterococcus faecium bacteremia. Clin Infect Dis. 2017;64(8):1026–1034.
   PubMed Web of Science ®Google Scholar
• Zasowski EJ, Claeys KC, Lagnf AM, et al. Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections. Clin Infect Dis. 2016;62(10):1242–1250.
   PubMed Web of Science ®Google Scholar
• Banach DB, Peaper DR, Fortune BE, et al. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients. Clin Transplant. 2016;30(3):306–311.
   PubMed Web of Science ®Google Scholar
• Tsai HY, Lee YL, Liu PY, et al. Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: results from the 2019-2020 nationwide surveillance of multicenter antimicrobial resistance in Taiwan (SMART). Int J Antimicrob Agents. 2021;58(1):106353.
   PubMed Web of Science ®Google Scholar